| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Plasmodium falciparum-induced anemia was characterized in Aotus monkeys repeatedly immunized by infection with P. falciparum (FVO strain) parasites, then cross-challenged with CAMP strain, or in monkeys receiving blood stage challenges as part of malaria vaccine trials. In 4 studies, 25 (30.5%) of 82 monkeys had at least a 50% reduction in hematocrit; mean day of maximum parasitemia was 12.5, whereas the mean day of minimum hematocrit was 18.8 (P < 0.0009). Decreased hematocrit levels were not associated with reticulocytosis until parasite densities decreased significantly from peak levels. Direct antibody tests to detect IgG and C3d on the surface of erythrocytes were negative. Nonantibody/noncomplement-mediated lysis of uninfected erythrocytes seems to be the principal cause of the anemia, and it also seems that bone marrow suppression and lysis of infected erythrocytes contributed to the anemia. Partial immunity-whether induced by repeated immunization with whole parasites or with vaccine-seems important to the development of anemia.
This article has been cited by other articles:
|
|
 |
|
  Q. Li, M. P. Kozar, T. W. Shearer, L. H. Xie, A. J. Lin, K. S. Smith, Y. Si, L. Anova, J. Zhang, W. K. Milhous, et al. Pharmacokinetics, Safety, and Hydrolysis of Oral Pyrroloquinazolinediamines Administered in Single and Multiple Doses in Rats Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2898 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Obaldia III Clinico-Pathological Observations on the Pathogenesis of Severe Thrombocytopenia and Anemia Induced by Plasmodium vivax Infections During Antimalarial Drug Efficacy Trials in Aotus Monkeys Am J Trop Med Hyg, July 1, 2007; 77(1): 3 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Lamikanra, D. Brown, A. Potocnik, C. Casals-Pascual, J. Langhorne, and D. J. Roberts Malarial anemia: of mice and men Blood, July 1, 2007; 110(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. McDevitt, J. Xie, G. Shanmugasundaram, J. Griffith, A. Liu, C. McDonald, P. Thuma, V. R. Gordeuk, C. N. Metz, R. Mitchell, et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia J. Exp. Med., May 15, 2006; 203(5): 1185 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Xie, Q. Li, A. J. Lin, K. Smith, J. Zhang, and D. S. Skillman New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1649 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Evans, D. S. Hansen, N. van Rooijen, L. A. Buckingham, and L. Schofield Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes Blood, February 1, 2006; 107(3): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. John, A. M. Moormann, P. O. Sumba, A. V. Ofulla, D. C. Pregibon, and J. W. Kazura Gamma Interferon Responses to Plasmodium falciparum Liver-Stage Antigen 1 and Thrombospondin-Related Adhesive Protein and Their Relationship to Age, Transmission Intensity, and Protection against Malaria Infect. Immun., September 1, 2004; 72(9): 5135 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dicko, A. D. Klion, M. A. Thera, I. Sagara, D. Yalcouye, M. B. Niambele, M. Sogoba, G. Dolo, A. Dao, D. A. Diallo, et al. The etiology of severe anemia in a village and a periurban area in Mali Blood, August 15, 2004; 104(4): 1198 - 1200. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
